DBND | JCPB | DBND / JCPB | |
Gain YTD | 3.358 | 3.614 | 93% |
Net Assets | 425M | 6.09B | 7% |
Total Expense Ratio | 0.45 | 0.38 | 118% |
Turnover | 142.00 | 57.00 | 249% |
Yield | 5.04 | 5.05 | 100% |
Fund Existence | 3 years | 6 years | - |
DBND | JCPB | |
---|---|---|
RSI ODDS (%) | 1 day ago46% | 1 day ago47% |
Stochastic ODDS (%) | 1 day ago50% | 1 day ago43% |
Momentum ODDS (%) | 1 day ago57% | 1 day ago54% |
MACD ODDS (%) | 1 day ago60% | 1 day ago50% |
TrendWeek ODDS (%) | 1 day ago60% | 1 day ago53% |
TrendMonth ODDS (%) | 1 day ago57% | 1 day ago52% |
Advances ODDS (%) | 4 days ago57% | 4 days ago52% |
Declines ODDS (%) | 9 days ago54% | 9 days ago48% |
BollingerBands ODDS (%) | 1 day ago41% | 1 day ago48% |
Aroon ODDS (%) | 1 day ago54% | 1 day ago41% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DRV | 28.27 | 2.39 | +9.23% |
Direxion Daily Real Estate Bear 3X ETF | |||
PDO | 13.77 | -0.06 | -0.43% |
PIMCO Dynamic Income Opportunities Fund | |||
FMF | 46.01 | -0.43 | -0.92% |
First Trust Managed Future Strategy ETF | |||
IBRN | 20.94 | -0.86 | -3.93% |
iShares Neuroscience and Healthcare ETF | |||
SMOT | 31.03 | -2.21 | -6.65% |
VanEck Morningstar SMID Moat ETF |
A.I.dvisor tells us that JCPB and EXE have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JCPB and EXE's prices will move in lockstep.
Ticker / NAME | Correlation To JCPB | 1D Price Change % | ||
---|---|---|---|---|
JCPB | 100% | +0.47% | ||
EXE - JCPB | 6% Poorly correlated | -2.92% | ||
DAKT - JCPB | 2% Poorly correlated | -7.77% | ||
CHRD - JCPB | -1% Poorly correlated | -12.38% |